SCHEMBL14908693

SCHEMBL14908693

COCCNc1cc(Br)cc2cccnc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 11/20 0.51
HSP90AB1 P08238 11/20 0.51
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
KDM4E B2RXH2 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
POLB P06746 2/20 0.47
MAPT P10636 2/20 0.47
HTT P42858 2/20 0.47
TDP2 O95551 1/20 0.47
FGB P02675 1/20 0.47
GAA P10253 1/20 0.47
THRB P10828 1/20 0.47
TSHR P16473 1/20 0.47
NR4A1 P22736 1/20 0.47
RECQL P46063 1/20 0.47
RAB9A P51151 1/20 0.47
BLM P54132 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077040 0.81 SMN1; SMN2 (0.44) HSP90AA1HSP90AB1ALDH1A1MEN1KMT2A
SCHEMBL9776348 0.77 ALDH1A1 (0.48) HSP90AA1HSP90AB1ALDH1A1MEN1KMT2A
SCHEMBL14910896 0.76 MEN1 (0.50) HSP90AA1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL14909856 0.76 KDM4E (0.52) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL22816626 0.71 KDM4E (0.43) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL3344053 0.70 NQO2 (0.53) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL30674020 0.70 NQO2 (0.53) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL28866735 0.70 MEN1 (0.50) MEN1KMT2AKDM4EPOLBHTT
SCHEMBL1255125 0.69 UTS2R (0.48) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL13856507 0.68 HSP90AA1 (0.80) HSP90AA1HSP90AB1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 EP disclosed
CN-102958918-B Novel tobacco amide derivatives or its salt FUJIFILM CORP. (JP) 2015-12-09 CN disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed
CN-102958918-A Novel nicotinamide derivatives or salts thereof FUJIFILM CORP 2013-03-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK HSP90AA1 2900/4885HSP90AB1 2303/4885ALDH1A1 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.